Short- and long-term outcome following thoracoamniotic shunting for fetal hydrothorax.
fetal hydrothorax
neurodevelopmental outcome
pulmonary outcome
thoracoamniotic shunting
Journal
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
17
01
2020
received:
10
10
2019
accepted:
09
02
2020
pubmed:
19
2
2020
medline:
15
12
2021
entrez:
19
2
2020
Statut:
ppublish
Résumé
To assess short- and long-term outcome in a cohort of fetuses diagnosed with hydrothorax (FHT) which underwent thoracoamniotic shunting in utero, and to examine the antenatal predictors of survival and of survival with normal neurodevelopmental outcome. This was a retrospective analysis of 132 fetuses that underwent thoracoamniotic shunting at our center between 1991 and 2014. Data were extracted from hospital obstetric and relevant neonatal intensive care and neonatal developmental follow-up databases. Outcomes included survival to discharge and survival with normal neurodevelopmental outcome beyond 18 months. Information on malformations, syndromes and genetic abnormalities were obtained from antenatal, postnatal and pediatric hospital records or by parent report. We compared pregnancy characteristics among those who survived vs non-survivors and among those with normal neurodevelopmental outcome vs those who were abnormal or died. We explored whether there was a trend in survival over the study period. The mean gestational age at diagnosis of FHT was 25.6 weeks. The fetus was hydropic at diagnosis in 61% of cases, 69% had bilateral effusions and 55% had bilateral shunts inserted. Other diagnoses were present in 24% of cases, two-thirds of which were discovered only postnatally. There were 16 intrauterine and 30 neonatal deaths, with a 65% survival rate overall. The mean gestational age at delivery of liveborns was 35.4 (range, 26.9-41.6) weeks, and 88/116 (76%) were preterm (< 37 weeks). Of 87 liveborn at the treatment center, 75% experienced some respiratory and/or cardiovascular morbidity after birth, many with a lengthy hospital stay (mean, 36 (range, 1-249) days). Overall, 84% of survivors were developmentally normal beyond 18 months and outcomes were better when pleural effusions were isolated, 92% of these cases being neurodevelopmentally normal. There was no trend in survival or neurodevelopmental outcome over time. Despite the presence of FHT and neonatal respiratory issues, most (89%) of the 55 survivors with relevant follow-up had no long-term pulmonary complications. Gestational age at delivery was the only factor independently predictive of both survival and survival with normal neurodevelopmental outcome. FHT is associated with other pathologies in a quarter of cases and carries a significant risk of prematurity, mortality and neonatal morbidity. The outcome is good in survivors but is best in isolated cases. Predictors of outcome at diagnosis are poor. Future improvement in diagnostics at time of identification of FHT may help to identify those that would benefit most from thoracoamniotic shunting. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
624-630Informations de copyright
© 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Références
Longaker MT, Laberge JM, Dansereau J, Langer JC. Primary fetal hydrothorax: natural history and management. J Pediatr Surg 1989; 24: 573-576.
Nicolaides KH, Azar GB. Thoraco-amniotic Shunting. Fetal Diagn Ther 1990; 5: 153-164.
Weber AM, Philipson EH. Fetal pleural effusion: a review and meta-analysis for prognostic indicators. Obstet Gynecol 1992; 79: 281-286.
Pettersen HN, Nicolaides KH. Pleural effusions. In Pleural Effusions, Fisk NM, Moise KJ (eds). Cambridge University Press: Cambridge, 1997; 261-272.
Aubard Y, Derouineau I, Aubard V, Chalifour V, Preux PM. Primary fetal hydrothorax: A literature review and proposed antenatal clinical strategy. Fetal Diagn Ther 1998; 13: 325-333.
Pellegrinelli JM, Kohler A, Kohler M, Weingertner AS, Favre R. Prenatal management and thoracoamniotic shunting in primary fetal pleural effusions: a single centre experience. Prenat Diagn 2012; 32: 467-471.
Yinon Y, Kelly EN, Ryan G. Fetal pleural effusions. Best Pract Res Clin Obstet Gynaecol 2008; 22: 77-96.
Yinon Y, Grisaru-Granovsky S, Chadda V, Windrim R, Seaward GR, Kelly EN, Beresovska O, Ryan G. Perinatal outcome following fetal chest shunt insertion for pleural effusions. Ultrasound Obstet Gynecol 2010; 36: 58-64.
Teoh TG, Ryan G, Johnson J, Winsor EJ. The role of fetal karyotyping from unconventional sources. Am J Obstet Gynecol 1996; 175: 873-877.
Bayley N. Bayley Scales of Infant Development, 2nd edn. 1993. Psychological Corp: San Antonio, TX.
Bayley N. Bayley Scales of Infant and Toddler Development®, Third Edition (Bayley-III®) 2005. Pearson Corp, Toronto, Ontario, Canada.
Squires J, Bricker D. Ages & Stages Questionnaires®, Third Edition (ASQ®-3). A parent-completed child-monitoring system. Paul H. Brookes Publishing Co., Inc: Baltimore, 2009.
Palisano R, Rosenbaum P, Walter S, Russel D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-223.
Mallmann MR, Graham V, Rösing B, Gottschalk I, Müller A, Gembruch U, Geipel A, Berg C. Thoracoamniotic Shunting for Fetal Hydrothorax: Predictors of Intrauterine Course and Postnatal Outcome. Fetal Diagn Ther 2017; 41: 58-65.
Smith RP, Illanes S, Denbow ML, Soothill PW. Outcome of fetal pleural effusions treated by thoracoamniotic shunting. Ultrasound Obstet Gynecol 2005; 26: 63-66.
Deurloo KL, Devlieger R, Lopriore E, Klumper FJ, Oepkes D. Isolated fetal hydrothorax with hydrops: a systematic review of prenatal treatment options. Prenat Diagn 2007; 27: 893-899.
Rustico MA, Lanna M, Coviello D, Smoleniec J, Nicolini U. Fetal pleural effusion. Prenat Diagn 2007; 27: 793-799.
Witlox RSGM, Klumper FJCM, Te Pas AB, van Zwet EW, Oepkes D, Lopriore E. Neonatal management and outcome after thoracoamniotic shunt placement for fetal hydrothorax. Arch Dis Child Fetal Neonatal Ed 2018; 103: F245-F249.
Derderian SC, Trivedi S, Farrell J, Keller R, Rand L, Goldstein R, Feldstein VA, Hirose S, MacKenzie TC. Outcomes of fetal intervention for primary hydrothorax. Pediatr Surg 2014; 49: 900-903.
Bianchi S, Lista G, Castoldi F, Rustico M. Congenital primary hydrothorax: effect of thoracoamniotic shunting on neonatal clinical outcome. J Matern Fetal Neonatal Med 2010; 23: 1225-1229.
Mussat P, Dommergues M, Parat S, Mandelbrot L, de Gamarra E, Dumez Y, Moriette G. Congenital chylothorax with hydrops: postnatal care and outcome following antenatal diagnosis. Acta Paediatr 1995; 84: 749-755.
Picone O, Benachi A, Mandelbrot L, Ruano R, Dumez Y, Dommergues M. Thoracoamniotic shunting for fetal pleural effusions with hydrops. Am J Obstet Gynecol 2004; 191: 2047-2050.
Caserio S, Gallego C, Martin P, Moral MT, Pallas CR, Galindo A. Congenital chylothorax: from foetal life to adolescence. Acta Paediatr 2010; 99: 1571-1577.
Peterson S, Kaur R, Thomas JT, Cincotta R, Gardener G. The Outcome of Isolated Primary Fetal Hydrothorax: A 10-Year Review from a Tertiary Center. Fetal Diagn Ther 2013; 34: 69-76.
Witlox RSGM, Lopriore E, Rijken M, Klumper FJCM, Oepkes D, van Klink JMM. Long-Term Neurodevelopmental and Respiratory Outcome after Intrauterine Therapy for Fetal Thoracic Abnormalities. Fetal Diagn Ther 2019; 45: 162-167.
Garner R, Kohen D. Changes in the prevalence of asthma among Canadian children. Health Rep 2008; 19: 45-50.
Klam S, Bigras BS, Hudon L. Predicting Outcome in Primary Fetal Hydrothorax. Fetal Diagn Ther 2005; 20: 366-370.